Similar articles

• Oral phosphate binders in patients with kidney failure.

  Moe SM, Block GA, Langman CB. Moe SM, et al. N Engl J Med. 2010 Sep 2;363(10):990; author reply 990. doi: 10.1056/NEJMc1005274. N Engl J Med. 2010. PMID: 20830820 No abstract available.
• Oral phosphate binders in patients with kidney failure.

  Tonelli M, Pannu N, Manns B. Tonelli M, et al. N Engl J Med. 2010 Apr 8;362(14):1312-24. doi: 10.1056/NEJMra0912522. N Engl J Med. 2010. PMID: 20375408 Review. No abstract available.
• Aluminum-free oral phosphate binder.

  Schneider H, Kulbe KD, Weber H, Streicher E. Schneider H, et al. Clin Nephrol. 1985;24 Suppl 1:S98-102. Clin Nephrol. 1985. PMID: 3842107
• Update on phosphate binders: The old and the new.

  Cashin J, Battistella M. Cashin J, et al. CANNT J. 2016 Jan-Mar;26(1):17-21; quiz 22-3. CANNT J. 2016. PMID: 27215057 No abstract available.
• New approaches to treatment of secondary hyperparathyroidism.

  Locatelli F, Limardo M, Pontoriero G. Locatelli F, et al. Curr Opin Investig Drugs. 2008 Apr;9(4):363-70. Curr Opin Investig Drugs. 2008. PMID: 18393103 Review.